Posts tagged: Aurinia Pharmaceuticals
Betaville IntelligenceFriday, 30 June 2023, 11:08 am
It's taken almost a year but Aurinia Pharmaceuticals, the US-listed biopharmaceutical company, has finally acquiesced to MKT Capital's demands and formally put itself up for sale. Below is a link to the press release that was issued last night:..
Read more...
Betaville IntelligenceThursday, 11 May 2023, 8:40 am
Another major shareholder in US-listed biopharmaceutical company Aurinia Pharmaceuticals has publicly come out against the board of the company.
Iljin, a longtime Korean investor in Aurinia with just over 6.1pc of the company, has written a letter to the board saying it does not intend to support the company's chairman, George Milne, along with several other board members, including Joseph Hagan...
Read more...
Betaville IntelligenceMonday, 24 April 2023, 2:38 pm
Arch rivals at Bloomberg have finally decided to follow up little old Betaville's recent story on the activists trying to shake things up at Aurinia Pharmaceuticals, the US-listed biopharmaceutical company...
Read more...
Betaville IntelligenceThursday, 23 March 2023, 7:18 pm
One of Aurinia Pharmaceutical's largest shareholders has formally submitted an application for a seat on the board of the US-listed company and reiterated its request for the group to consider a formal sale of the business.
The MKT Tactical Fund, which owns 3.2pc of Aurinia Pharmaceuticals, submitted the request for the board seat this week to Aurinia's chief executive, Peter Greenleaf, and chairman, George Milne Junior...
Read more...
Exclusive to Betaville Intelligence subscribersFriday, 1 July 2022, 3:50 pm
Friday, 11 February 2022, 8:21 am
Has GlaxoSmithKline truly given up its pursuit of Aurinia Pharmaceuticals, the US-listed drug developer?
Last year Betaville Intelligence reported that GSK was one of the pharmaceutical giants circling Aurinia but now The Times is reporting the FTSE 100-listed group is looking at a different takeover target...
Read more...
Betaville IntelligenceThursday, 13 January 2022, 7:42 pm
It's been a while since there has been a fresh bid rumour about Aurinia, the US-listed biopharmaceutical company that featured several times on Betaville late last year.
But STAT - a specialist US-based healthcare publication - has just set tongues wagging...
Read more...
Betaville IntelligenceFriday, 22 October 2021, 9:51 pm
Rivals at Bloomberg appear at the moment to be super keen on following up little old Betaville's alerts.
Earlier this week the financial media behemoth followed Betaville's UNCOOKED Alert on Falck Renewables, the Italy-listed renewable energy group, and just now Bloomie followed up last week's UNCOOKED Alert on Aurinia Pharmaceuticals, the US-listed rare disease developer. Below is the link to a Seeking Alpha summary:..
Read more...
Exclusive to Betaville Intelligence subscribersTuesday, 12 October 2021, 4:04 pm